What’s new in quality & regulatory – 2021 edition
Continual Improvement Webinar
Expires: December 8, 2023
This "Continual Improvement" webinar will provide an overview of new regulatory changes and issues that have the potential to affect laboratory operations. The speakers also will discuss potential legislation affecting the regulation of laboratory developed tests (LDTs) found in the Verifying Accurate, Leading-edge IVCT Development (VALID) Act.
Jenny Nosbisch, MBA
CLIA Program Manager
Integrity and Compliance Office
Mayo Clinic, Rochester, Minnesota
Shannon Bennett, MS, MBA, CM/QOE (ASQ)
Directory of Regulatory Affairs
Department of Laboratory Medicine and Pathology
Mayo Clinic, Rochester, Minnesota
Upon completion of this activity, participants should be able to:
This series is appropriate for laboratory administrators and managers, quality assurance and control staff, supervisors, and other laboratory personnel who are dedicated to continuous quality and process improvement.
The following types of credit are offered for this event:
Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 1.0 P.A.C.E.® contact hour.
Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for Clinical Laboratory Sciences for the State of California. This program has been approved for 1.0 contact hour.
Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for the Clinical Laboratory Sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for Supervision/Administration, Quality Control/Quality Assurance credit. This program has been approved for 1.0 contact hour.
1. Watch the video.
2. Complete the post-test and evaluation that launches immediately following the video.
3. Generate and print your certificate(s).
Level of instruction for this program is intermediate.
Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.
Contact us: mcleducation@mayo.edu